Pharmaceutical
Funds, stocks, and articles on Dividend Vision tagged "Pharmaceutical".
66 tickers carry the Pharmaceutical tag on Dividend Vision (8 ETFs, 58 Stocks). The highest distribution rates are PRGO (7.27%), SNY (5.82%), PFE (5.73%).
Explore income investments by theme
Dividend Vision tags organize funds, stocks, and research around the characteristics that investors commonly want to explore. Asset tags describe features found in our ticker research, including asset class, market exposure, income strategy, sector, and portfolio structure. Article topics describe the subjects covered by our editorial content. Selecting a tag brings those resources together so you can move from an idea to the relevant assets and educational material.
Tags are a starting point for research, not a rating or recommendation. A fund can carry several tags because it may combine multiple exposures or strategies. For example, an ETF might use options, focus on technology companies, and seek dividend income at the same time. Similar-looking funds can also have different tags when their mandates, holdings, or distribution approaches differ. Review each asset page, fund documents, risks, expenses, and distribution history before drawing conclusions.
Use the directory below to browse broadly, or select a tag to see matching tickers and articles. The asset screener offers more precise filtering when you want to combine themes with yield, distribution frequency, fund type, or other criteria. Tags reflect the information available in Dividend Vision's research and may change as products and coverage evolve. Inclusion only describes how an item is categorized; it does not indicate suitability for any investor.
Loading tagged content…
66 tickers
Grouped by asset type. Ticker links open the full per-asset page.
ETFs (8)
| Ticker | Issuer | Name | Dist. Rate | Inception |
|---|---|---|---|---|
| PPH | VanEck | VanEck Pharmaceutical ETF | 1.25% | Dec 20, 2011 |
| IHE | iShares | iShares U.S. Pharmaceuticals ETF | 1.09% | May 1, 2006 |
| PJP | Invesco | Invesco Dynamic Pharmaceuticals ETF | 0.96% | Jun 23, 2005 |
| XPH | State Street | SPDR® S&P Pharmaceuticals ETF | 0.27% | Jun 19, 2006 |
| FTXH | First Trust | First Trust Nasdaq Pharmaceuticals ETF | 0.10% | Sep 20, 2016 |
| PBPH | Portfolio Building Block | Portfolio Building Block World Pharma and Biotech Index ETF | — | Nov 25, 2025 |
| PEPT | REX Shares | REX ETF Trust - REX Peptide ETF | — | Oct 14, 2026 |
| TDNA | T. Rowe Price | T. Rowe Price Biotech ETF | — | Sep 17, 2026 |
Stocks (58)
| Ticker | Issuer | Name | Dist. Rate |
|---|---|---|---|
| PRGO | — | Perrigo Company PLC | 7.27% |
| SNY | — | Sanofi | 5.82% |
| PFE | — | Pfizer Inc. | 5.73% |
| BMY | — | Bristol-Myers Squibb Co. | 4.10% |
| GSK | — | GSK plc | 3.56% |
| NVS | — | Novartis AG | 3.16% |
| NVO | — | Novo Nordisk A/S | 2.97% |
| VTRS | — | Viatris Inc. | 2.67% |
| ZTS | — | Zoetis Inc. | 2.62% |
| ABBV | — | AbbVie Inc. | 2.42% |
| MRK | — | Merck & Co., Inc. | 2.34% |
| AMGN | — | Amgen Inc. | 2.29% |
| GILD | — | Gilead Sciences, Inc. | 2.10% |
| JNJ | — | Johnson & Johnson | 2.03% |
| TAK | — | Takeda Pharmaceutical Company Limited | 1.47% |
| HLN | — | Haleon plc | 1.25% |
| AZN | — | AstraZeneca PLC | 1.24% |
| RDY | — | Dr. Reddy's Laboratories Limited | 0.63% |
| OGN | — | Organon & Co. | 0.58% |
| LLY | — | Eli Lilly and Co. | 0.54% |
| AKAN | — | Akanda Corp. | — |
| ALKS | — | Alkermes plc | — |
| AMLX | — | Amylyx Pharmaceuticals, Inc. | — |
| AMPH | — | Amphastar Pharmaceuticals Inc. | — |
| AMRN | — | Amarin Corporation plc | — |
| AMRX | — | Amneal Pharmaceuticals, Inc. | — |
| ANIP | — | ANI Pharmaceuticals, Inc. | — |
| BCRX | — | BioCryst Pharmaceuticals, Inc. | — |
| BIIB | — | Biogen Inc. | — |
| BIOA | — | BioAge Labs, Inc. | — |
| COLL | — | Collegium Pharmaceutical, Inc. | — |
| ELAN | — | Elanco Animal Health Inc. | — |
| ETON | — | Eton Pharmaceuticals, Inc. | — |
| HIMS | — | Hims & Hers Health Inc. | — |
| HROW | — | Harrow, Inc. | — |
| INCY | — | Incyte Corp. | — |
| INDV | — | Indivior Pharmaceuticals, Inc. | — |
| IRWD | — | Ironwood Pharmaceuticals, Inc. | — |
| KNSA | — | Kiniksa Pharmaceuticals International, plc | — |
| LNTH | — | Lantheus Holdings Inc. | — |
| LQDA | — | Liquidia Corporation | — |
| MAIA | — | MAIA Biotechnology Inc. | — |
| MNOV | — | MediciNova Inc | — |
| MTNB | — | Matinas BioPharma Holdings Inc | — |
| NBIX | — | Neurocrine Biosciences Inc. | — |
| NNVC | — | NanoViricides Inc | — |
| NTHI | — | NeOnc Technologies Holdings, Inc. Common Stock | — |
| OSTX | — | OS Therapies Incorporated | — |
| PBH | — | Prestige Consumer Healthcare Inc. | — |
| PCRX | — | Pacira BioSciences, Inc. | — |
| PLX | — | Protalix Biotherapeutics Inc | — |
| SUPN | — | Supernus Pharmaceuticals, Inc. | — |
| TEVA | — | Teva Pharmaceutical Industries Limited | — |
| TLRY | — | Tilray Brands, Inc. | — |
| TRLV | — | Trulieve Cannabis Corp. | — |
| UTHR | — | United Therapeutics Corp. | — |
| VRTX | — | Vertex Pharmaceuticals Inc. | — |
| XERS | — | Xeris Biopharma Holdings, Inc. | — |
Articles
Blog posts covering this theme or the tickers tagged with it.
Nothing is tagged with that yet. Browse all tags below.
All tags
Asset tags come from our ticker research; article topics come from the blog.
Asset tags
Article topics
About Dividend Vision tags
How are asset tags assigned?
Asset tags are based on our review of a product's strategy, structure, holdings, and stated exposure. They are maintained as the underlying product information and our coverage change.
Can an asset have more than one tag?
Yes. An asset may combine an income approach, asset class, sector, or market theme, so using several descriptive tags can provide a more complete picture of its mandate.
Why might similar funds have different tags?
Funds that appear similar can follow different indexes, use different instruments, or apply different options and distribution policies. Tags reflect those distinctions when they are material to understanding the product.
How should I use tags in my research?
Use tags to discover related assets and educational articles, then verify the details on the asset page and in official fund documents. A tag is descriptive and is not investment advice.